E Squiccimarro, F Jiritano, GF Serraino… - Journal of Clinical …, 2021 - mdpi.com
Thrombocytopenia and impaired platelet function are known as intrinsic drawbacks of cardiac surgery and extracorporeal life supports (ECLS). A number of different factors …
S Takahashi, N Yokoyama, Y Watanabe… - Circulation …, 2020 - jstage.jst.go.jp
Background: The frequency and predictors of thrombocytopenia after transcatheter aortic valve implantation (TAVI) are unclear. Methods and Results: This study enrolled 342 …
The publication of the 2020 ACC/AHA guidelines for the management of patients with heart valve disease, while updating essential steps for clinical evaluation and diagnosis, and …
Y Yamada, D Miura, A Takamori, E Nogami… - BMC Research …, 2020 - Springer
Objective Thrombocytopenia is common after transcatheter aortic valve implantation (TAVI) and is associated with mortality and major complications, although the underlying …
T Bakchoul, O Borst, R Riessen, J Lucic, M Gawaz… - Th …, 2019 - thieme-connect.com
We describe a rare case of autoimmune heparin-induced thrombocytopenia after transcatheter aortic valve implantation in which antibodies against platelet factor 4/heparin …
S Fugar, O Behnamfar, AK Okoh… - Catheterization and …, 2020 - Wiley Online Library
Background There is little data on the impact of chronic thrombocytopenia (CTP) on outcomes after transcatheter aortic valve repair (TAVR). Most studies are from single centers …
N Kuyama, K Kaikita, M Ishii, N Tabata, S Oda… - Circulation …, 2023 - jstage.jst.go.jp
Background: Subclinical leaflet thrombosis occasionally occurs after transcatheter aortic valve implantation (TAVI), but its exact etiology and relationship with thrombogenicity remain …
WJ Gomes - International Journal of Cardiology, 2019 - internationaljournalofcardiology.com
Thrombocytopenia has long been recognized as a likely event following aortic valve replacement (AVR), either with mechanical or biological prosthesis, and its consequences …
Y Yamada, D Miura, A Takamori, E Nogami, J Yunoki… - 2020 - researchsquare.com
Objective: Thrombocytopenia is common after transcatheter aortic valve implantation (TAVI) and is associated with mortality and major complications, although the underlying …